SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001232524-18-000148
Filing Date
2018-08-13
Accepted
2018-08-13 18:42:41
Documents
2
Period of Report
2018-08-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 8770
2 EDGAR SUPPORTING DOCUMENT poaokeefe.txt EX-24 3673
  Complete submission text file 0001232524-18-000148.txt   13980
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BEECKEN PETTY O'KEEFE & COMPANY 131 S. DEARBORN STREET, SUITE 2800 CHICAGO IL 60603
Business Address
O'Keefe Kenneth W (Reporting) CIK: 0001397661 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 181013761